Ethyl (6S)-6-[4-(5-fluoro-3-pyrazin-2-yl-2-pyridinyl)piperidin-1-yl]-2-azaspiro[3.4]octane-2-carboxylate
C24H30FN5O2 — CID 171850061
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl (6S)-6-[4-(5-fluoro-3-pyrazin-2-yl-2-pyridinyl)piperidin-1-yl]-2-azaspiro[3.4]octane-2-carboxylate
Ethyl (6S)-6-[4-(5-fluoro-3-pyrazin-2-yl-2-pyridinyl)piperidin-1-yl]-2-azaspiro[3.4]octane-2-carboxylate (PubChem CID 171850061) has the molecular formula C24H30FN5O2 and a molecular weight of 439.54 g/mol. Its IUPAC name is ethyl (6S)-6-[4-(5-fluoro-3-pyrazin-2-yl-2-pyridinyl)piperidin-1-yl]-2-azaspiro[3.4]octane-2-carboxylate.
Molecular Properties
| Compound Name | Ethyl (6S)-6-[4-(5-fluoro-3-pyrazin-2-yl-2-pyridinyl)piperidin-1-yl]-2-azaspiro[3.4]octane-2-carboxylate |
|---|---|
| PubChem CID | 171850061 |
| Molecular Formula | C24H30FN5O2 |
| Molecular Weight | 439.54 g/mol |
| Exact Mass | 439.24 |
| IUPAC Name | ethyl (6S)-6-[4-(5-fluoro-3-pyrazin-2-yl-2-pyridinyl)piperidin-1-yl]-2-azaspiro[3.4]octane-2-carboxylate |
| SMILES | CCOC(=O)N1CC2(CC[C@H](N3CCC(c4ncc(F)cc4-c4cnccn4)CC3)C2)C1 |
| InChI | InChI=1S/C24H30FN5O2/c1-2-32-23(31)30-15-24(16-30)6-3-19(12-24)29-9-4-17(5-10-29)22-20(11-18(25)13-28-22)21-14-26-7-8-27-21/h7-8,11,13-14,17,19H,2-6,9-10,12,15-16H2,1H3/t19-/m0/s1 |
| InChIKey | IJNCAAKCGJSFJB-IBGZPJMESA-N |
| XLogP | 3.87 |
| TPSA | 71.45 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 439.54 |
| LogP ≤ 5 | 3.87 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171850061 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.